Looking to Navigate Compliance, Generate Sales, and Build your Unlicensed Medicine Portfolio?
Empowering you to focus on your strengths while we expertly manage your Medicinal Cannabis business. Leave the heavy lifting to us – we’ve got your back!
UK Prescriptions
In 2024, private medicinal cannabis prescriptions doubled according the Care Quality Commission (CQC)
Rapid Expansion
The UK medicinal cannabis market is projected to grow from its current value (approximately £700 million in 2025) to potentially over £1 billion by 2028
Our Mission
At Medicexum, we empower businesses and healthcare professionals in the medicinal cannabis sector with expert guidance, innovative strategies, and compliance-driven solutions to advance safe access and industry growth
Market Growth
- Patient Access: More patients are likely to be prescribed medical cannabis as awareness among healthcare professionals and the general public grows.
- Insurance Coverage: There could be advancements in making cannabis-based medicines eligible for broader insurance or NHS support.
Opportunity
Cannabis Based-Medicinal Products (CBMPs)
Import/Export Support
At Medicexum, we offer solutions for importation of medical cannabis into the UK through fully licensed, EU GMP-compliant producers, ensuring regulatory approvals, seamless compliance, and safe delivery for patients and healthcare providers.
Product Selection
We can support identfying various medical cannabis product forms, including vapes for fast relief, gummies for discretion, flower for inhalation, oils for precise dosing, and capsules for consistent effects, catering to diverse patient needs.
B2B Access
Medicexum supports B2B clients with expert guidance on licensing, compliance, sourcing EU GMP-certified products, and market strategies to drive success in the medical cannabis industry.
Research & development
Study of clinical outcomes of medicinal cannabis therapy for ADHD
The UK Medical Cannabis Registry has published several observational studies indicating that patients prescribed cannabis-based medicinal products reported improvements in conditions such as anxiety, sleep disorders, and general health-related quality of life. For instance, a study focusing on patients with Attention Deficit Hyperactivity Disorder (ADHD) found significant enhancements in anxiety levels, sleep quality, and overall health-related quality of life over a 12-month period. The treatment was well tolerated, with fewer than one in five individuals reporting adverse events during the therapy.
As of 2024, the number of medical cannabis patients in the UK is estimated to be approximately only 0.09% of the UK’s population of around 67 million.
%
Approximately 28 million of the population in the UK live with chronic pain. With a significant proportion might explore medical cannabis as an alternative or supplement to traditional pain management.
Surveys suggest that upto 6% of the UK adult population have expressed an interest in using medical cannabis if it were more accessible. Among patients managing chronic conditions, this number could be much higher, particularly as awareness and availability increase.
Ready to break into the UK medicinal cannabis market while staying fully compliant? Partner with Medicexum today! Our expert team delivers tailored strategies and solutions to drive your success. Let’s turn your vision into reality - get in touch now!
How We Can Help
Identify Suppliers
We operate within a fully compliant supply chain, adhering to all regulatory standards to ensure the safe and legal production, distribution, and supply of medical cannabis products.
Setup Compliant Supply Chain
We specialise in setting up fully compliant medical cannabis supply chains, ensuring regulatory adherence, seamless operations, and access to high-quality products.
Calling All Suppliers, Producers & B2B Partners! Collaborate with Medicexum to Bring Compliant Medicinal Cannabis to UK Patients
Medicexum Blog | UK Medical Cannabis News & Insights
Cannabis Cultivation Market 2025: Growth Trends, Key Players, and Future Outlook
The global cannabis cultivation market is experiencing rapid expansion, driven by increasing legalisation, medical acceptance, and rising consumer demand. According to a recent market report, the industry is expected to grow from $179.32 billion in 2024 to $208.64...
Medical Cannabis Flower Specification in the UK: Regulations, Testing & Compliance
Medical cannabis has become an important therapeutic option in the UK, with strict regulations governing its quality and safety. The British Pharmacopoeia (BP) and European Pharmacopoeia (Ph. Eur.) set the microbial, chemical, and physical quality standards...
Comparative Growth in Medical Cannabis Markets: Germany and the UK
As Europe navigates the evolving landscape of medical cannabis, Germany and the United Kingdom are emerging as two of the most promising markets. A recent report highlighting a staggering 1,000% increase in German medical cannabis prescriptions from March to December...
The Case for UK Farmers Growing Medicinal Cannabis—And How Medicexum Can Help Entrepreneurs Enter the Market
A recent article in The Independent highlights Conservative MP David Mundell’s push for UK farmers to cultivate medicinal cannabis to boost rural economies and create new business opportunities. His argument is simple but compelling: allowing British farmers to grow...
Breaking into the UK Medical Cannabis Market: A Startup’s Guide to Success
The UK medical cannabis industry is no longer a distant frontier—it’s a rapidly growing market filled with opportunity. With the right strategy, entrepreneurial start-ups can position themselves at the forefront of this evolving landscape. But what does it take to...